Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · see citing works

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,232 · see citing works

Evaluation of survival data and two new rank order statistics arising in its consideration.

Mantel, N. (1966) · PubMed · Cited by 7,516 · see citing works

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · see citing works

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

Determination of subcutaneous tumor size in athymic (nude) mice

Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830 · see citing works

Encyclopedia of Pharmaceutical Technology

Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,795 · see citing works

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.

Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382 · see citing works

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

Maeda, H., Bharate, G. Y., & Daruwalla, J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,171 · see citing works

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.

Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934 · see citing works

Liposome application: problems and prospects.

Barenholz, Y. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00090-x · Cited by 659 · see citing works

Tumor measurement in the nude mouse

Euhus, D., Hudd, C., LaRegina, M. C., & Johnson, F. E. (1986) · Journal of Surgical Oncology · doi:10.1002/jso.2930310402 · Cited by 607 · see citing works

Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications

Pinto‐Alphandary, H., Andremont, A., & Couvreur, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00121-1 · Cited by 428 · see citing works

In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy

Tardi, P. G., Johnstone, S. A., Harasym, N. L., Xie, S., Harasym, T. O., Zisman, N., Harvie, P., Bermudes, D. G., & Mayer, L. D. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.06.028 · Cited by 357 · see citing works

Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties

Zucker, D., Marcus, D., Barenholz, Y., & Goldblum, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.036 · Cited by 340 · see citing works

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., & Janoff, A. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0118 · Cited by 332 · see citing works

Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.

Schroeder, A., Avnir, Y., Weisman, S., Najajreh, Y., Gabizon, A., Talmon, Y., Kost, J., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la0631668 · Cited by 239 · see citing works

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

Houghton, P. J., Cheshire, P. J., Myers, L., Stewart, C. F., Synold, T. W., & Houghton, J. A. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685553 · Cited by 227 · see citing works

Optimizing Combination Chemotherapy by Controlling Drug Ratios

Mayer, L. D., & Janoff, A. S. (2007) · Molecular Interventions · doi:10.1124/mi.7.4.8 · Cited by 214 · see citing works

Clinical Pharmacology of Liposomal Anthracyclines: Focus on Pegylated Liposomal Doxorubicin

Solomon, R. O., & Gabizón, A. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.001 · Cited by 200 · see citing works

Tumor Necrosis Factor α Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response

Seynhaeve, A. L. B., Hoving, S., Schipper, D., Vermeulen, C. E., de Wiel‐Ambagtsheer, G. A., van Tiel, S. T., Eggermont, A. M. M., & ten Hagen, T. L. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1599 · Cited by 175 · see citing works

Combination cancer therapy: Presidential address.

Frei, E. (1972) · PubMed · Cited by 167 · see citing works

Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.

Tardi, P. G., CHOICE, E., Masin, D., Redelmeier, T. E., Bally, M. B., & Madden, T. D. (2000) · PubMed · Cited by 160 · see citing works

Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy

Barenholz, Y. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120017482 · Cited by 157 · see citing works

Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular Defense

Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148 · see citing works

Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo

Tardi, P. G., Gallagher, R. C., Johnstone, S. A., Harasym, N. L., Webb, M. S., Bally, M. B., & Mayer, L. D. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.014 · Cited by 135 · see citing works

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug

Pakunlu, R. I., Wang, Y., Saad, M., Khandare, J. J., Starovoytov, V., & Minko, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.010 · Cited by 131 · see citing works

Liposomal and Nonliposomal Drug Pharmacokinetics after Administration of Liposome-Encapsulated Vincristine and Their Contribution to Drug Tissue Distribution Properties

Krishna, R., Webb, M. S., St.-Onge, G., & Mayer, L. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29494-5 · Cited by 129 · see citing works

Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.

Mayer, L. D., Bally, M. B., Loughrey, H. C., Masin, D., & Cullis, P. R. (1990) · PubMed · Cited by 111 · see citing works

In Vitro and in Vivo Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading

Abraham, S. A., McKenzie, C., Masin, D., Ng, R., Harasym, T. O., Mayer, L. D., & Bally, M. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1131-03 · Cited by 110 · see citing works

Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.

Thompson, J., George, E. O., Poquette, C. A., Cheshire, P. J., Richmond, L. B., de Graaf, S. S. N., Ma, M., Stewart, C. F., & Houghton, P. J. (1999) · PubMed · Cited by 86 · see citing works

Influence of Drug Release Characteristics on the Therapeutic Activity of Liposomal Mitoxantrone

Lim, H. J., Masin, D., Madden, T. D., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36596-6 · Cited by 83 · see citing works

Liposomes: From the Bench to the Bed

Crommelin, D. J. A., & Storm, G. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120017488 · Cited by 81 · see citing works

Sterically stabilized liposomes in cancer therapy and gene delivery.

Lasiç, D. D., Jj, V., & Working, P. K. (1999) · PubMed · Cited by 81 · see citing works

The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation

Storm, G., van Bloois, L., Brouwer, M., & Crommelin, D. J. A. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90008-2 · Cited by 51 · see citing works

Synergistic interaction between topotecan and microtubule-interfering agents

Bahadori, H. R., Green, M. A., & Catapano, C. V. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100327 · Cited by 49 · see citing works

Enzymatic Assays for Quality Control and Pharmacokinetics of Liposome Formulations: Comparison with Nonenzymatic Conventional Methodologies

Shmeeda, H., Even‐Chen, S., Honen, R., Cohen, R., Weintraub, C., & Barenholz, Y. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)67017-5 · Cited by 47 · see citing works

Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: stability, pharmacokinetic and therapeutic evaluation

Liu, J., Hong, R., Cheng, W., Hong, K., Chang, F., & Tseng, Y. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200208000-00005 · Cited by 43 · see citing works

Preclinical Studies with Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes

Gabizón, A., Pappo, O., Goren, D., Chemla, M., Tzemach, D., & Horowitz, A. T. (1993) · Journal of Liposome Research · doi:10.3109/08982109309150734 · Cited by 32 · see citing works

In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan

Hao, Y., Deng, Y., Chen, Y., Ai-jun, H., Zhang, Y., & Wang, K.-Z. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.10.0006 · Cited by 30 · see citing works

Liposomal Bleomycin: Increased Therapeutic Activity and Decreased Pulmonary Toxicity in Mice

D Arndt, R. Z. (2001) · Drug Delivery · doi:10.1080/107175401300002685 · Cited by 30 · see citing works

Amphipathic Weak Base Loading into Preformed Liposomes Having a Transmembrane Ammonium Ion Gradient: From the Bench to Approved Doxil

Barenholz, Y. (2016) · CRC Press eBooks · doi:10.1201/9780849397271-5 · Cited by 30 · see citing works

The Antioxidant Tempamine: In Vitro Antitumor and Neuroprotective Effects and Optimization of Liposomal Encapsulation and Release

Wasserman, V., Kizelsztein, P., Garbuzenko, O. B., Kohen, R., Ovadia, H., Tabakman, R., & Barenholz, Y. (2007) · Langmuir · doi:10.1021/la060218k · Cited by 25 · see citing works

Design of liposome-based drug carriers: From basic research to application as approved drugs

Barenholz, Y. (1998) · Elsevier eBooks · doi:10.1016/b978-044482917-7/50031-4 · Cited by 23 · see citing works

Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels

Güthlein, F., Burger, A. M., Brandl, M., Fiebig, H., Schubert, R., Unger, C., & Massing, U. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200209000-00003 · Cited by 23 · see citing works

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · see citing works

Extracellular vesicles as drug delivery systems: Lessons from the liposome field

van der Meel, R., Fens, M. H. A. M., Vader, P., van Solinge, W. W., Eniola‐Adefeso, O., & Schiffelers, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.049 · Cited by 486 · see citing works

Liposome-based drug co-delivery systems in cancer cells

Vahed, S. Z., Salehi, R., Davaran, S., & Sharifi, S. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.11.073 · Cited by 308 · see citing works

Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review

Li, B., Shao, H., Gao, L., Li, H., Sheng, H., & Zhu, L. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2094498 · Cited by 298 · see citing works

Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy

Xiao, B., Si, X., Han, M. K., Viennois, É., Zhang, M., & Merlin, D. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01245g · Cited by 160 · see citing works

Drug nanocrystallisation within liposomes

Li, T., Cipolla, D. C., Rades, T., & Boyd, B. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.001 · Cited by 155 · see citing works

Multi-responsive chitosan-based hydrogels for controlled release of vincristine

Far, B. F., Omrani, M., Naimi‐Jamal, M. R., & Javanshir, S. (2023) · Communications Chemistry · doi:10.1038/s42004-023-00829-1 · Cited by 149 · see citing works

Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview

Teja, P. K., Mithiya, J., Kate, A. S., Bairwa, K., & Chauthe, S. K. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153890 · Cited by 116 · see citing works

Carbon nanotubes-liposomes conjugate as a platform for drug delivery into cells

Karchemsky, F., Zucker, D., Barenholz, Y., & Regev, O. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.037 · Cited by 97 · see citing works

Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer

Alven, S., Nqoro, X., Buyana, B., & Aderibigbe, B. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050406 · Cited by 93 · see citing works

Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy

Gowda, R. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000184 · Cited by 90 · see citing works

Nanoparticle-based combination drug delivery systems for synergistic cancer treatment

Choi, J. Y., Thapa, R. K., Yong, C. S., & Kim, J. O. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0252-1 · Cited by 87 · see citing works

Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin

Rui, M., Xin, Y., Li, R., Ge, Y., Feng, C., & Xu, X. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00732 · Cited by 84 · see citing works

Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy

Zucker, D., Andriyanov, A. V., Steiner, A., Raviv, U., & Barenholz, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.003 · Cited by 84 · see citing works

Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft

Shaikh, I. M., Tan, K.-B., Chaudhury, A., Liu, Y., Tan, B.-J., Tan, B. M. J., & Chiu, G. N. C. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.025 · Cited by 76 · see citing works

Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids

Avnir, Y., Turjeman, K., Tulchinsky, D., Sigal, A., Kizelsztein, P., Tzemach, D., Gabizon, A., & Barenholz, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025721 · Cited by 72 · see citing works

Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model

Franco, M. S., Roque, M. C., de Barros, A. L. B., Silva, J. D. O., Cassali, G. D., & Oliveira, M. C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.011 · Cited by 65 · see citing works

Therapeutic Efficacy of Combining PEGylated Liposomal Doxorubicin and Radiofrequency (RF) Ablation: Comparison between Slow-Drug-Releasing, Non-Thermosensitive and Fast-Drug-Releasing, Thermosensitive Nano-Liposomes

Andriyanov, A. V., Koren, E., Barenholz, Y., & Goldberg, S. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092555 · Cited by 63 · see citing works

Nanomedicines in the future of pediatric therapy.

Sosnik, A., & Carcaboso, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.004 · Cited by 54 · see citing works

Materials innovation for co-delivery of diverse therapeutic cargos

Godsey, M. E., Suryaprakash, S., & Leong, K. W. (2013) · RSC Advances · doi:10.1039/c3ra43094d · Cited by 54 · see citing works

Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs

Alven, S., & Aderibigbe, B. A. (2020) · Nanomaterials · doi:10.3390/nano10081556 · Cited by 53 · see citing works

Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders

Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 56 · see citing works

Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria

Waknine-Grinberg, J. H., Even‐Chen, S., Avichzer, J., Turjeman, K., Bentura-Marciano, A., Haynes, R. K., Weiss, L., Allon, N., Ovadia, H., Golenser, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072722 · Cited by 53 · see citing works

Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer

Zeng, F., Ju, R., Liu, L., Xie, H.-J., Mu, L.-M., Zhao, Y. L., Yan, Y., Hu, Y., Wu, J.-S., & Lü, W.-L. (2015) · Oncotarget · doi:10.18632/oncotarget.5382 · Cited by 52 · see citing works

Synergistic co-loading of vincristine improved chemotherapeutic potential of pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer

Ghosh, S., Lalani, R., Maiti, K., Banerjee, S., Bhatt, H., Bobde, Y., Patel, V., Biswas, S., Bhowmick, S., & Misra, A. R. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102320 · Cited by 52 · see citing works

Nanoscale Particulate Systems for Multidrug Delivery: Towards Improved Combination Chemotherapy

Liboiron, B. D., & Mayer, L. D. (2014) · Therapeutic Delivery · doi:10.4155/tde.13.149 · Cited by 50 · see citing works

Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes

Qiu, L., Gao, M., & Xu, Y. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91463 · Cited by 49 · see citing works

Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer

Jiang, M., Zhang, R., Wang, Y., Jing, W., Liu, Y., Ma, Y., Sun, B., Wang, M., Chen, P., Liu, H., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00381 · Cited by 47 · see citing works

Codelivery of Salinomycin and Chloroquine By Liposomes Enables Synergistic Antitumor Activity In Vitro

Xie, F., Zhang, S., Liu, J., Gong, Z., Yang, K., Zhang, H., Lü, Y., Zou, H. L., Yuan, Y., Chen, Y., et al. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0125 · Cited by 45 · see citing works

Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition

Gao, M., Xu, Y., & Qiu, L. (2016) · Journal of Liposome Research · doi:10.1080/08982104.2016.1185731 · Cited by 44 · see citing works

Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy

Banudevi, S., Swaminathan, S., & Maheswari, K. U. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1073762 · Cited by 41 · see citing works

Liposomes for malaria management: the evolution from 1980 to 2020

Memvanga, P. B., & Nkanga, C. I. (2021) · Malaria Journal · doi:10.1186/s12936-021-03858-0 · Cited by 42 · see citing works

Nanomedicine Strategies for sustained, Controlled and Targeted Treatment of Cancer Stem Cells

Gao, J., Li, W., Guo, Y., & Feng, S. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0261 · Cited by 40 · see citing works

Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer

Borges, G. S. M., Silva, J. D. O., Fernandes, R. S., de Souza, A. M., Cassali, G. D., Yoshida, M. I., Leite, E. A., de Barros, A. L. B., & Ferreira, L. A. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116678 · Cited by 39 · see citing works

Treatment of Experimental Brain Metastasis with MTO-Liposomes: Impact of Fluidity and LRP-Targeting on the Therapeutic Result

Orthmann, A., Zeisig, R., Süss, R., Lorenz, D., Lemm, M., & Fichtner, I. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0723-7 · Cited by 34 · see citing works

Liposomes Co- encapsulating Anticancer Drugs in Synergistic Ratios as an Approach to Promote Increased Efficacy and Greater Safety

Franco, M. S., & Oliveira, M. C. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666180420170124 · Cited by 34 · see citing works

Doxil® — The First FDA-Approved Nano-Drug: From an Idea to a Product

Barenholz, Y. (2020) · doi:10.1201/9781003125259-16 · Cited by 30 · see citing works

Therapeutic PEG-ceramide Nanomicelles Synergize With Salinomycin to Target Both Liver Cancer Cells and Cancer Stem Cells

Wang, M., Xie, F., Wen, X., Chen, H., Zhang, H., Liu, J., Zhang, H., Zou, H. L., Yuan, Y., Chen, Y., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0408 · Cited by 30 · see citing works

Green Approaches for Cancers Management: An Effective Tool for Health Care

Gupta, J., Ahuja, A., & Gupta, R. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210119091826 · Cited by 29 · see citing works

Determination of Nonspherical Morphology of Doxorubicin-Loaded Liposomes by Atomic Force Microscopy

Takahashi, N., Higashi, K., Ueda, K., Yamamoto, K., & Moribe, K. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.009 · Cited by 28 · see citing works

Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy

Franco, M. S., & Oliveira, M. C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.009 · Cited by 28 · see citing works

Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes

Peres-Filho, M. J., dos Santos, A. P., Nascimento, T. L., de Ávila, R. I., Ferreira, F. S., Valadares, M. C., & Lima, E. M. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0830-1 · Cited by 27 · see citing works

Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system

Xie, F., Xu, W., Yin, C., Zhang, G., Zhong, Y., & Gao, J. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i10.735 · Cited by 26 · see citing works

A combination of liposomal sunitinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse

Maitani, Y., Saito, H., Seishi, Y., Iwase, Y., Yamauchi, T., Higashiyama, K., & Sugino, T. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.723215 · Cited by 24 · see citing works

Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities

Ghosh, S., Lalani, R., Patel, V., Bhowmick, S., & Misra, A. R. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1676721 · Cited by 24 · see citing works

A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect

Bjørnstad, R., Reiten, I. N., Knudsen, K. S., Schjøtt, J. D., & Herfindal, L. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122379 · Cited by 23 · see citing works

Optimization and Efficacy Study of Synergistic Vincristine Coloaded Liposomal Doxorubicin Against Breast and Lung Cancer

Ghosh, S., Lalani, R., Maiti, K., Banerjee, S., Patel, V., Bhowmick, S., & Misra, A. R. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0169 · Cited by 23 · see citing works

Short and Long-Term Effects of the Exposure of Breast Cancer Cell Lines to Different Ratios of Free or Co-Encapsulated Liposomal Paclitaxel and Doxorubicin

Franco, M. S., Roque, M. C., & Oliveira, M. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040178 · Cited by 22 · see citing works

Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS

Gondim, B. L. C., Catarino, J. D. S., de Sousa, M. A. D., Silva, M. D. O., Lemes, M. R., Carvalho-Costa, T. M., Nascimento, T. R. D. L., Machado, J. R., Rodrigues, V., Oliveira, C. J. F., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191014171354 · Cited by 22 · see citing works

Dual Nanoparticle Drug Delivery: the Future of Anticancer therapies?

King, M. R., & Mohamed, Z. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0378 · Cited by 21 · see citing works

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

Zulfiqar, B., Mahroo, A., Nasir, K., Farooq, R. K., Jalal, N., Rashid, M. U., & Asghar, K. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s119362 · Cited by 21 · see citing works

Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice

Andriyanov, A. V., Portnoy, E., Koren, E., Inesa, S., Eyal, S., Goldberg, S. N., & Barenholz, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.018 · Cited by 20 · see citing works

PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors

Grabarnick, E., Andriyanov, A. V., Han, H., Eyal, S., & Barenholz, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122181 · Cited by 18 · see citing works

Nanocarriers for Delivery of Herbal Based Drugs in Breast Cancer - An Overview

Wani, K. D., Tarawadi, K., & Kaul-Ghanekar, R. (2015) · Journal of nano research · doi:10.4028/www.scientific.net/jnanor.34.29 · Cited by 16 · see citing works

Liposomes in Drug Delivery: Status and Advances

Hu, Y., Ju, R.-J., Zeng, F., Qi, X., & Lü, W.-L. (2021) · Biomaterial engineering · doi:10.1007/978-3-662-49320-5_1 · Cited by 14 · see citing works

Nanoscale Delivery Systems for Multiple Drug Combinations in Cancer

Cao, Y., Wang, B., Lou, D., Wang, Y., Hao, S., & Zhang, L. (2011) · Future Oncology · doi:10.2217/fon.11.109 · Cited by 14 · see citing works

Modulating the Self-Assembly of a Camptothecin Prodrug with Paclitaxel for Anticancer Combination Therapy: A Molecular Dynamics Approach

Mitra, A., Roy, R., & Paul, S. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c04798 · Cited by 11 · see citing works

Role and Application of Biocatalysts in Cancer Drug Discovery

Sengupta, S., Das, P., Sharma, S., Shukla, M. K., Kumar, R., Tonk, R. K., Pandey, S., & Kumar, D. (2023) · Catalysts · doi:10.3390/catal13020250 · Cited by 11 · see citing works

Chemical and physical characterization of remotely loaded bupivacaine liposomes: comparison between large multivesicular vesicles and small unilamellar vesicles

Cohen, R., Steiner, A., Kanaan, H., & Barenholz, Y. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20609b · Cited by 11 · see citing works

Targeted delivery of anticancer drugs: new trends in lipid nanocarriers

Oliveira, M. S., Mendes, L. P., & Torchilin, V. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00018-0 · Cited by 8 · see citing works

Effective loading of incompatible drugs into nanosized vesicles: a strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings

Fathi, H. A., Yousry, C., Elsabahy, M., El‐Badry, M., & El-Gazayerly, O. N. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122852 · Cited by 7 · see citing works

Preparation of liposomes co-encapsulating doxorubicin and mifepristone for treating multidrug-resistant cancer

Kawano, K., Furuya, A., Matsuda, Y., Kimura, C., Yamaguchi, K., Wakabayashi, S., Taniguchi, K., Ozaki, K., & Hattori, Y. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104605 · Cited by 4 · see citing works

Exploration of the cardinal formulation parameters influencing the encapsulation and physicochemical properties of co-loaded anticancer dual drug nanoliposomes

Ghosh, S., Mishra, P., Banerjee, S., Maiti, K., Khopade, A. J., Misra, A. R., Sawant, K. K., & Bhowmick, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103295 · Cited by 4 · see citing works

Preparation of Functional Vincristine Liposomes for Treatment of Invasive Breast Cancer

Zeng, F. (2021) · Biomaterial engineering · doi:10.1007/978-3-662-49320-5_10 · Cited by 4 · see citing works

Nanomorphology tuning in doxorubicin-loaded liposomes via cooling-induced doxorubicin-crystallization and membrane phase transition

Nishimura, K., Fujimoto, T., Tokumoto, T., Higashi, K., Hidaka, R., Ueda, K., Morita, T., & Moribe, K. (2025) · Chemical Communications · doi:10.1039/d5cc02434j · Cited by 3 · see citing works

Unlocking the full potential of piperine-loaded nanocarriers for cancer treatment

Kumar, G., Ruivinho, B., Virmani, T., Brandão, P., Choudhary, P., Chouhan, N. K., Kumar, M., Sharma, A., Akhtar, M. S., Afzal, O., et al. (2025) · Therapeutic Delivery · doi:10.1080/20415990.2025.2542107 · Cited by 3 · see citing works

Nanotechnology Enters the Renal Cancer Drug Delivery Arena: A Review

Sharon, M. (2018) · Novel Approaches in Drug Designing & Development · doi:10.19080/napdd.2018.04.555631 · Cited by 2 · see citing works

Liposome-engineered therapeutics: A promising frontier in ovarian cancer treatment

Mavaddat, H., Peyrovinasab, A., Kabiri, S. S., Basiri, N., Khayatan, I., Razavi, S. M., Hekmati, M., Esmaeili, A., Jamialahmadi, T., Abdolghaffari, A. H., et al. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103138 · Cited by 1 · see citing works

Designing Drug Delivery Vehicles based on N-(2-Hydroxypropyl) Methacrylamide

Are, R. P., & Babu, A. R. (2024) · Current Computer - Aided Drug Design · doi:10.2174/0115734099278986231228070823 · Cited by 1 · see citing works

Preparation of Functional Vincristine Liposomes for Treatment of Invasive Breast Cancer

Zeng, F. (2017) · Springer eBooks · doi:10.1007/978-3-662-49231-4_10-1 · Cited by 1 · see citing works

Development of PEGylated Liposomes

Henderson, I. C. (2011) · doi:10.1002/9783527634057.ch28

Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer

Jones, N. R., Banerjee, S., & Robertson, G. P. (2013)

Liposomes in Drug Delivery: Status and Advances

Hu, Y., Ju, R.-J., Zeng, F., Qi, X., & Lü, W.-L. (2018) · Biomaterial engineering · doi:10.1007/978-3-662-49231-4_1-1

Preparation of Functional Vincristine Liposomes for Treatment of Invasive Breast Cancer

Zeng, F. (2018) · Springer Reference Technik · doi:10.1007/978-3-662-49231-4_10-2

Rational design of linkers in polymer–drug conjugates

Dhiman, N., Awasthi, R., Kharkwal, H., Sharma, B., & Kulkarni, G. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91663-9.00014-x

Liposome-mediated drug codelivery approaches for treatment of cancer

Souri, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33548-8.01009-0

Two Drug Combination Anti-cancer Therapy Based on Topotecan and Vincristine Co-Remote-Loaded into PEGylated Nanoliposomes

Zucker, D., & Barenholz, Y. (2009) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3841792

Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy

Zucker, D., Andriyanov, A. V., Steiner, A., Raviv, U., & Barenholz, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.003 · Cited by 84 · see citing works

Liposomes Co- encapsulating Anticancer Drugs in Synergistic Ratios as an Approach to Promote Increased Efficacy and Greater Safety

Franco, M. S., & Oliveira, M. C. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666180420170124 · Cited by 34 · see citing works

In Vitro and in Vivo Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading

Abraham, S. A., McKenzie, C., Masin, D., Ng, R., Harasym, T. O., Mayer, L. D., & Bally, M. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1131-03 · Cited by 110 · see citing works

Use of nanoscale delivery systems to maintain synergistic drug ratiosin vivo

Dicko, A., Mayer, L. D., & Tardi, P. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538678 · Cited by 75 · see citing works